Science Explorer Back to mapMap
Discussion
Researcher · University of Bradford · United Kingdom

Mohammad Isreb

Mohammad Isreb publishes mostly in Molecular Biology, Pharmaceutical Science and Biomedical Engineering, on topics such as Drug Solubulity and Delivery Systems, Additive Manufacturing and 3D Printing Technologies and Nanoparticle-Based Drug Delivery.

ORCID 0000-0003-4042-3940 OpenAlex
World rank
#2,530,371
of 7,710,434 ranked researchers
Rank in United Kingdom
#178,407
of 367,258
Works
40
Citations
1.2k
Citations per work
29.7
h-index
14
i10-index 19Top 55% in Molecular Biology
Mohammad Isreb

What does Mohammad Isreb research?

Mohammad Isreb's work is mostly in Biochemistry, Genetics and Molecular Biology (22%), Pharmacology, Toxicology and Pharmaceutics (13%), Engineering (9%).

Everything else: 17 works · 42.5% of their workLife Sciences: 14 works · 35.2% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 22.2% of their workMolecular Biology: 6 works · 15.7% of their workCancer Research: 3 works · 6.5% of their workPharmacology, Toxicology and Pharmaceutics: 5 works · 13.0% of their workPharmaceutical Science: 5 works · 13.0% of their workPhysical Sciences: 9 works · 22.3% of their workEngineering: 4 works · 9.3% of their workBiomedical Engineering: 4 works · 9.3% of their workChemistry: 3 works · 6.5% of their workOrganic Chemistry: 3 works · 6.5% of their workMaterials Science: 3 works · 6.5% of their workBiomaterials: 3 works · 6.5% of their workTHEIR WORKMohammad Isreb40works
Life Sciences35%Physical Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1742.5%
    1. Biochemistry, Genetics and Molecular Biology922.2%
    2. Pharmacology, Toxicology and Pharmaceutics513.0%
    1. Engineering49.3%
    2. Chemistry36.5%
    3. Materials Science36.5%
  1. 1Molecular Biology16% of their works
  2. 2Pharmaceutical Science13% of their works
  3. 3Biomedical Engineering9% of their works
  4. 4Organic Chemistry6% of their works
  5. 5Cancer Research6% of their works
  6. 6Biomaterials6% of their works

Research topics

Which keywords describe Mohammad Isreb's research?

The keywords of their largest research topics: Drug Delivery, Nanoparticles, Biogenesis, Cancer, Cyclodextrins, Solid Dispersions, 3D Printing and Additive Manufacturing.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Drug Delivery163 topics
  2. Nanoparticles112 topics
  3. Biogenesis92 topics
  4. Cancer92 topics
  5. Cyclodextrins81 topic
  6. Solid Dispersions81 topic
  7. 3D Printing61 topic
  8. Additive Manufacturing61 topic
  9. Cancer Therapy61 topic
  10. Nanocarriers61 topic
  11. Bioprinting51 topic
  12. Chitosan51 topic
  13. Exosomes51 topic
  14. Extracellular Vesicles51 topic
  15. Injection Molding51 topic
  16. Mucosal51 topic
  17. Optimization51 topic
  18. Tissue Engineering51 topic
  19. Gene Expression41 topic
  20. MicroRNA41 topic

Where does Mohammad Isreb work?

Mohammad Isreb's main affiliation in the publication record is University of Bradford, United Kingdom.

How many publications and citations does Mohammad Isreb have?

OpenAlex counts 40 works and 1,189 citations for Mohammad Isreb, an h-index of 14, ranking #2,530,371 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mohammad Isreb. Posts are plain text and can be reported.